Literature DB >> 19656173

Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.

Rachel J Smith1, Ronald E See, Gary Aston-Jones.   

Abstract

The orexin/hypocretin system has recently been implicated in reward-processing and addiction. We examined the involvement of the orexin system in cue-induced reinstatement of extinguished cocaine-seeking by administering the orexin 1 receptor antagonist SB-334867 (SB) or the orexin 2 receptor antagonist 4-pyridylmethyl (S)-tert-leucyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (4PT) prior to reinstatement testing. Male Sprague Dawley rats self-administered cocaine in 2-h sessions for 10 days, followed by extinction training. Reinstatement of cocaine-seeking was elicited by presentation of tone + light cues previously paired with cocaine infusions. SB (10, 20 and 30 mg/kg) dose-dependently decreased cue-induced reinstatement of cocaine-seeking without significantly affecting responding during late extinction. 4PT (10 and 30 mg/kg) did not significantly alter cue-induced reinstatement. In separate experiments, the highest doses of SB and 4PT had no significant effect on established cocaine self-administration, and 4PT reduced spontaneous activity in a locomotor test to a greater extent than SB. Finally, SB (30 mg/kg) had no effect on the acquisition of cocaine-paired cues during a Pavlovian cocaine-stimulus conditioning session in the operant chamber. Pretreatment with SB prior to the Pavlovian acquisition session had no effect on subsequent cue-induced reinstatement of cocaine-seeking elicited by those cues. However, pretreatment with SB prior to a second reinstatement session in the same animals significantly attenuated the expression of cue-induced reinstatement. These results show that orexin transmission at the orexin 1 receptor, but not the orexin 2 receptor, is necessary for the reinstatement of cocaine-seeking elicited by drug-paired cues and that orexin signaling is not critical for cocaine reinforcement or cocaine-stimulus conditioning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656173      PMCID: PMC2771107          DOI: 10.1111/j.1460-9568.2009.06844.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  57 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

Review 2.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

3.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

4.  The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse.

Authors:  J L Rogers; S Ghee; R E See
Journal:  Neuroscience       Date:  2007-10-22       Impact factor: 3.590

5.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

Review 6.  Medication development for addictive disorders: the state of the science.

Authors:  Frank J Vocci; Jane Acri; Ahmed Elkashef
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

7.  Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.

Authors:  Y Ishii; J E Blundell; J C G Halford; N Upton; R Porter; A Johns; P Jeffrey; S Summerfield; R J Rodgers
Journal:  Behav Brain Res       Date:  2005-02-28       Impact factor: 3.332

8.  Behavioral state instability in orexin knock-out mice.

Authors:  Takatoshi Mochizuki; Amanda Crocker; Sarah McCormack; Masashi Yanagisawa; Takeshi Sakurai; Thomas E Scammell
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

9.  Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

Authors:  Stephanie L Borgland; Sharif A Taha; Federica Sarti; Howard L Fields; Antonello Bonci
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

Review 10.  Role of lateral hypothalamic orexin neurons in reward processing and addiction.

Authors:  Gary Aston-Jones; Rachel J Smith; David E Moorman; Kimberlei A Richardson
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

View more
  112 in total

1.  Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Natalie E Zlebnik; Marilyn E Carroll
Journal:  Neurosci Lett       Date:  2012-06-02       Impact factor: 3.046

2.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 3.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

4.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

5.  Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement.

Authors:  James R Shoblock; Natalie Welty; Leah Aluisio; Ian Fraser; S Timothy Motley; Kirsten Morton; James Palmer; Pascal Bonaventure; Nicholas I Carruthers; Timothy W Lovenberg; Jamin Boggs; Ruggero Galici
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

Review 6.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

7.  Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference.

Authors:  Gregory C Sartor; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

8.  Role of orexin/hypocretin in conditioned sucrose-seeking in rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

9.  Neuronal activation in orbitofrontal cortex subregions: Cfos expression following cue-induced reinstatement of cocaine-seeking behavior.

Authors:  Aneesh Bal; Jennifer Gerena; Doris I Olekanma; Amy A Arguello
Journal:  Behav Neurosci       Date:  2019-05-06       Impact factor: 1.912

10.  Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.